Shiga toxin-converting bacteriophages (Stx phages) carry the stx gene and convert nonpathogenic bacterial strains into Shiga toxin-producing bacteria. Previous studies have shown that high densities of free and infectious Stx phages are found in environments polluted with feces and also in food samples. Taken together, these two findings suggest that Stx phages could be excreted through feces, but this has not been tested to date. In this study, we purified Stx phages from 100 fecal samples from 100 healthy individuals showing no enteric symptoms. The phages retrieved from each sample were then quantified by quantitative PCR (qPCR). In total, 62% of the samples carried Stx phages, with an average value of 2.6 × 10(4) Stx phages/g. This result confirms the excretion of free Stx phages by healthy humans. Moreover, the Stx phages from feces were able to propagate in enrichment cultures of stx-negative Escherichia coli (strains C600 and O157:H7) and in Shigella sonnei, indicating that at least a fraction of the Stx phages present were infective. Plaque blot hybridization revealed lysis by Stx phages from feces. Our results confirm the presence of infectious free Stx phages in feces from healthy persons, possibly explaining the environmental prevalence observed in previous studies. It cannot be ruled out, therefore, that some positive stx results obtained during the molecular diagnosis of Shiga toxin-producing Escherichia coli (STEC)-related diseases using stool samples are due to the presence of Stx phages.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754710PMC
http://dx.doi.org/10.1128/AEM.01158-13DOI Listing

Publication Analysis

Top Keywords

stx phages
44
stx
14
phages
12
phages feces
12
fecal samples
8
healthy individuals
8
shiga toxin-producing
8
previous studies
8
free stx
8
escherichia coli
8

Similar Publications

Intestinal Carriage of Two Distinct -Carrying Strains by a Child with Uncomplicated Diarrhea.

Pathogens

November 2024

Department Clinical Biology, Laboratory of Microbiology and Infection Control, Belgian National Reference Centre for STEC/VTEC, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), 1090 Brussels, Belgium.

Two distinct -carrying () strains, isolated from a child with uncomplicated diarrhea fifteen weeks apart, were characterized by combining short- and long-read sequencing to compare their genetic relatedness. One strain was characterized as Shiga toxin-producing (STEC)/typical enteropathogenic (tEPEC) O63:H6 with a repertoire of virulence genes including , (α2-subtype), , and . The other STEC with serotype O157:H16, reported for the first time as -carrying in this study, possessed, in addition, (ε-subtype) and , amongst other virulence-related genes.

View Article and Find Full Text PDF

Engineered smart microbes that deliver therapeutic payloads are emerging as treatment modalities, particularly for diseases with links to the gastrointestinal tract. Enterohemorrhagic (EHEC) is a causative agent of potentially lethal hemolytic uremic syndrome. Given concerns that antibiotic treatment increases EHEC production of Shiga toxin (Stx), which is responsible for systemic disease, novel remedies are needed.

View Article and Find Full Text PDF
Article Synopsis
  • Shiga toxin-producing E. coli (STEC) causes severe gastrointestinal issues, particularly linked to Stx2, which poses greater risks than Stx1.
  • A study of 71 strains in the O145:H28 lineage reveals the dynamic nature of Stx phages, including their acquisition, transfer, and variations affecting Stx2 production levels.
  • Short-tailed Stx2 phages are associated with higher production levels of Stx2 than long-tailed variants, highlighting genetic differences that influence these levels.
View Article and Find Full Text PDF

Engineered smart microbes that deliver therapeutic payloads are emerging as treatment modalities, particularly for diseases with links to the gastrointestinal tract. Enterohemorrhagic (EHEC) is a causative agent of potentially lethal hemolytic uremic syndrome. Given concerns that antibiotic treatment increases EHEC production of Shiga toxin (Stx), which is responsible for systemic disease, novel remedies are needed.

View Article and Find Full Text PDF
Article Synopsis
  • Shiga toxin-producing Escherichia coli (STEC) causes severe abdominal pain and diarrhea, which can lead to serious complications like haemolytic uremic syndrome (HUS), especially in vulnerable populations such as children and the elderly.
  • Traditional antibiotics can worsen outcomes by increasing toxin production, so treatment mainly focuses on supportive care instead.
  • Ongoing research into antivirulence strategies aims to develop small molecule inhibitors that block the Shiga toxin pathway, with new compounds being evaluated, although they haven't yet succeeded in advancing through clinical trials.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!